Abstract
We report results of a retrospective chart review to evaluate factors predicting short-term outcome of patients with ulcerative colitis treated by corticosteroids. Between January 1992 and December 1997, we treated 71 patients with ulcerative colitis (44 with severe and 27 with moderately severe disease). Forty-nine patients were treated by conventional prednisolone therapy and 22 patients by steroid pulse therapy. There were no differences in clinical or endoscopic improvement between the two treatments. Clinical examination showed that 41 patients entered remission, 17 patients improved, and 13 patients did not respond. Endoscopically, 26 patients entered remission, 30 patients improved, and 15 patients did not respond. Extent of disease, type of disease (first attack, relapsing, or chronic active type), and endoscopic findings were factors useful in predicting short-term outcome of medical treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Truelove SC, Witts LJ: Cortisone in ulcerative colitis: Final report on a therapeutic trial. BMJ 2:1041-1048, 1955
Truelove SC, Jewell DP: Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1:1067-1070, 1974
Truelove SC, Willoughby CP, Lee EG, Kettlewell MGW: Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 2:1086-1088, 1978
Järnerot G, Rolny P, Sandberg-Gertzén H: Intensive intravenous treatment of ulcerative colitis. Gastroenterology 89:1005-1013, 1985
Hyde GM, Jewell DP: The management of severe ulcerative colitis. Aliment Pharmacol Ther 11:419-424, 1997
Rosenberg W, Ireland A, Jewell DP: High-dose methylprednisolone in the treatment of active ulcerative colitis. J Clin Gastroenterol 12:40-41, 1990
Oshitani N, Kitano A, Matsumoto T, Kobayashi K: Corticosteroids for the management of ulcerative colitis. J Gastroenterol 30(suppl 8):118-120, 1995
Inoue M: Kaiyosei daichoen no shindan kijunan. Annual report of the Research Committee for Inflammatory Bowel Disease. Ministry of Health and Welfare, Japan, 1990, pp 26-28 (in Japanese)
Matts SGF: The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 30:393-407, 1961
Oshitani N, Kitano A, Fukushima R, Okabe H, Kashima K, Nakamura S, Obata A, Matsumoto T, Okawa K, Kobayashi K: Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment. Digestion 46:107-113, 1990
Goligher JC, Hoffman DC, de Dombal FT: Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation. BMJ 4:703-706, 1970
Schjønsby H, Heimann P, Kremer D, Nordgård K, Raugstad TS, Ringheim R, Stray O: Intensive treatment in severe acute attacks of ulcerative colitis. Acta Med Scand 603(suppl):43-46, 1977
Meyers S, Lerer PK, Feuer EJ, Johnson JW, Janowitz HD: Predicting the outcome of corticoid therapy for acute ulcerative colitis: Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol 9:50-54, 1987
Fan PT, Yu DTY, Clements PJ, Fowlston S, Eisman J, Bluestone R: Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisolone. J Lab Clin Med 91:625-634, 1978
Richter MB, Woo P, Panayi GS, Trull A, Unger A, Shepherd P: The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis. Clin Exp Immunol 53:51-59, 1983
Sales DJ, Kirsner JB: The prognosis of inflammatory bowel disease. Arch Intern Med 143:294-299, 1983
Hendriksen C, Kreisner S, Binder V: Long-term prognosis in ulcerative colitis-based on results from a regional patient group from the country of Copenhagen. Gut 26:158-163, 1985
Oshitani N, Kitano A, Nakamura S, Obata A, Hashimura H, Hiki M, Matsumoto T, Okawa K, Kobayashi K: Clinical and prognostic features of rectal sparing in ulcerative colitis. Digestion 42:39-43, 1989
Meyers S, Lerer PK, Feuer EJ, Johnson JW, Janowitz HD: Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, doubleblind clinical trial. J Clin Gastroenterol 9:50-54, 1987
Chakravarty BJ: Predictors and the rate of medical treatment failure in ulcerative colitis. Am J Gastroenterol 88:852-855, 1993
Gulati R, Rawal KK, Kumar N, Jain M, Puri AS, Govil A, Sachdeva AK, Chaudhary A: Course of severe ulcerative colitis in northern India. Trop Gastroenterol 16:19-23, 1995
Travis SPL, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MGW, Jewell DP: Predicting outcome in severe ulcerative colitis. Gut 38:905-910, 1996
Kelly JK, Gabos S: The pathogenesis of inflammatory polyps. Dis Colon Rectum 30:251-254, 1987
Jewell DP: Medical management of severe ulcerative colitis. Int J Colorect Dis 3:186-189, 1988
Banez AV, Yamanishi F, Crans CA: Endoscopic colonic decompression of toxic megacolon, placement of colonic tube, and steroid colonclysis. Am J Gastroenterol 82:692-694, 1987
Riedler L, Wohlgenannt D, Stoff F, Thaler W, Schmid KW: Endoscopic decompression in “toxic megacolon.” Surg Endosc 3:51-53, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oshitani, N., Matsumoto, T., Jinno, Y. et al. Prediction of Short-Term Outcome for Patients with Active Ulcerative Colitis. Dig Dis Sci 45, 982–986 (2000). https://doi.org/10.1023/A:1005589428082
Issue Date:
DOI: https://doi.org/10.1023/A:1005589428082